Home » News and Views » Alan Green talks to Venture Life Group #VLG CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University.

Alan Green talks to Venture Life Group #VLG CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University.

By Alan Green in News and Views on 17th November 2020.

Alan Green talks to Venture Life Group (AIM: VLG) CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University. Sharon also discusses the group progress to date in 2020, and summarises the current investment proposition for investors

Tags: alan green, Alan Green CEO Brand Communications, alliance pharma, APH, asda, dentyl, dentyl dual action, disinplus, Jerry Randall, kelocote, lloyds pharmacy, mermaid dentyl, NOVUS COMMUNICATIONS CEO ALAN GREEN, pharmasource, self care products, Sharon Collins, ultradex, unicorn dentyl, venture life group, VLG

Alan Green talks to Venture Life Group #VLG CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University.

Leave a comment Cancel reply

Recent Posts